Neurotronic, Inc. announced the first clinical outcomes of the NECTAR III and NECTAR IV trials evaluating the company’s ...

Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the ...

CUC Inc., a provider of health care management and operational support services headquartered in Tokyo, Japan, announced it ...

ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. Accor ...

Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intr ...

In this retrospective cohort study designed to assess long-term safety outcomes of drug-coated devices (DCDs) versus ...

Embolization, Inc. announced that its polymer-based coil intended for arterial and venous embolization in peripheral ...

Surmodics, Inc. announced new real-world results from the PROWL registry evaluating the company’s Pounce thrombectomy pl ...

InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter ...

Surmodics, Inc. announced results from a sex-specific analysis of its ongoing PROWL registry evaluating real-world use of the ...

Venova Medical announced the enrollment of the first patients in the VENOS-3 pivotal study of the company’s Velocity perc ...

Insights from PERT/DVT, limb salvage, and aortic team members on effective networking that lasts longer than the launch ...